NASSAU, Bahamas and SAN FRANCISCO, Jan. 9, 2025 /PRNewswire/ -- Roivios, a clinical-stage medical device company, and Caresyntax, a global…
JERSEY CITY, N.J., Jan. 9, 2025 /PRNewswire/ -- Outcomes Matter Innovations, LLC ("OMI") today announced a co-development agreement with Regional…
Despite high borrowing costs and extended hold times in 2024, dealmaking roared ahead for healthcare private equity with a heavy…
Calgary, Alberta--(Newsfile Corp. - January 9, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) is pleased to announce…
Offers an end-to-end platform for patient recruitment, data management, Biostatistics and regulatory submission FREMONT, CALIFORNIA / ACCESSWIRE / January 9,…
LONDON, GB / ACCESSWIRE / January 9, 2025 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that it…
Accelerating IMPT-314 in large B-cell lymphoma; remain on track to initiate pivotal trial in the 3rd line+ setting in 2025…
A 4-week treatment with IMG-007 resulted in a mean reduction in eczema area and severity index (EASI) of 77% and…
Cannabix Technologies Inc. Cannabix Breath Collection Unit (“BCU”) with Breath Cartridge technology VANCOUVER, British Columbia, Jan. 09, 2025 (GLOBE NEWSWIRE)…
Two additional TEASE-3 participants who recently completed 24 months of therapy showed no disease progression, consistent with prior results. A…